-
CONTACT
Contact Information
- 주소: 서울시 강서구 마곡동로 55, 8층(07802)
- 사업자등록번호: 109-86-37282
- 대표자: Choongseong Han
- 대표번호 : +82-2-2088-8886
- 팩스번호: +82-2-2088-8884
- 이메일 : support@nexel.co.kr
-
- Home
- Resources
- Patent
Patent
# | 명칭 | 등록번호 | 비고 |
---|---|---|---|
24 | Methods for preparing heart organoid derived from human pluripotent Stem Cell and heart organoid derived from human pluripotent Stem Cell prepared by thereof | 1-2014-037580-7/KR | Stem Cell organoid |
23 | Compositions and Method for Treating or Preventing Fibrosis | PCT/IB2019/001136 | fibrosis treatment |
22 | Methods for producing in vitro wilson's disease model using human pluripotent stem cell and in vitro wilson's disease model produced by thereof | 10-2159877/ KR PCT/KR2019/001278 | Wilson's dsease model |
21 | Composition for predicting prognosis of senere alcoholic hepatitis and use thereof | 10-2171799/ KR PCT/KR2019/002392 | Biomarker for alcholic hepatitis |
20 | Method for differentiation of hepatocyte | 10-2038503/ KR | Hepatic maturation |
19 | Method for enhancing metabolizing activity of hepatocytes | 10-2018783/ KR | Hepatic differentiation |
18 | Composition for Idiopathic Pulmonary Fibrosis treatment or prevention containing recombinant protein for Idiopathic Pulmonary Fibrosis treatment or prevention | 10-2161892/ KR PCT/KR2018/012801 | Use of NP-011 for IPF disease |
17 | Composition for Alzheimer"s disease treatment or prevention containing recombinant protein for Alzheimer"s disease treatment or prevention | 10-2129179/ KR PCT/KR2018/012800 | Use of NP-011 for Alzheimer"s disease |
16 | Composition for myocardial infarction treatment or prevention containing recombinant protein for myocardial infarction treatment or prevention | 10-2129178/ KR PCT/KR2018/012780 | Use of NP-011 for MI disease |
15 | Methods for differentiation of glutamatergic neuron from human plufipotent stem cell using insulin-like growth factor 1 receptor inhibitor | 10-2183230/ KR PCT/KR2019/007266 | Neural differentiation |
14 | Simple method for differentiating human pluripotent stem cells into highly proliferative vascular endothelial cells for hemophilia A treatment | 10-2161910/ KR | Vascular endothlial cells differentiation |
13 | Methods for preparing in vitro cultured hepatocytes using er stress reliever and in vitro cultured hepatocytes prepared by thereof (Partition application: primary Hepatocytes) | 10-2145134/ KR | Hepatocyte cultivation |
12 | Methods for preparing in vitro cultured hepatocytes using er stress reliever and in vitro cultured hepatocytes prepared by thereof(Partition application: liver cancer cells) | 10-2159886/ KR | Hepatocyte cultivation |
11 | Methods for preparing in vitro cultured hepatocytes using er stress reliever and in vitro cultured hepatocytes prepared by thereof | 10-2060256/ KR PCT/KR2018/012609 | Hepatocyte cultivation |
10 | Method for generating human pluripotent stem cells derived functional cardiomyocytes by cell differentiation with maturation and hauman pluripotent stem cell derived functional cardiomyocytes generated by thereof | 10-1994035/ KR PCT/KR2018/004195 | Differentiation and production of mature cardiomyocytes |